Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Oncolytics lung cancer drug shrinks tumors in 92 percent of patients in trial
Oncolytics lung cancer drug shrinks tumors in 92 percent of patients in trial
Oncolytics lung cancer drug shrinks tumors in 92 percent of patients in trial
Submitted by
admin
on September 9, 2013 - 10:47am
Source:
Reuters
News Tags:
lung cancer
Oncolytics
Reolysin
Headline:
Oncolytics lung cancer drug shrinks tumors in 92 percent of patients in trial
Do Not Allow Advertisers to Use My Personal information
